Stuart Therapeutics has announced the successful completion of its Phase 3 clinical trial for ST-100...

Pantheon Vision has announced the successful completion of its third meeting with the FDA review tea...

Nacuity Pharmaceuticals has announced that the FDA has granted Fast Track Designation to its investi...

HelpMeSee has announced new partnerships with the University of Southern California (USC)/LA General...

Glaukos has shared several promising clinical updates for its iDose sustained-release procedural pha...

Formycon, in collaboration with its licensing partner Klinge Biopharma, has announced that the Europ...

RhyGaze, a biotechnology company with headquarters in Basel, Switzerland, and Philadelphia, PA, has ...

InflammX Therapeutics, Inc. has announced an option agreement with Bausch + Lomb, granting the latte...

Ocugen has announced that the first patient in its Phase 1 clinical trial for OCU200, a potential tr...

Outlook Therapeutics has finalized the analysis of 12-week safety and efficacy data from the NORSE E...